CD44 and cancer: CD44 plays not only a role in EMT but also is a dedifferentiation marker that has been formerly reported to be highly expressed in anaplastic lesions and is correlated with cancer stem cells in PDAC [56, 57] and Caveolin 1 which was formerly suggested to be considered as an aggressiveness marker in PDAC [58].